🟢 Atea Pharmaceuticals is trading 5% up today amid broader biotech rally

Atea Pharmaceuticals is trading 5.16% up now at $5.00, alongside a broader biotechnology rally.

• Biotech ETF XBI is up 2.09%; sentiment is supported by Argenx’s announced tender offer for Forte Biosciences and renewed industry M&A speculation.
• No clear company-specific announcement explains the August 6, 2026 move.
• Atea’s latest update scheduled second-quarter results and a business update for August 12, rather than August 6.